Having identified an “urgent” need for guardrails to keep healthcare AI from veering into an avoidable ditch, the Coalition for Health AI has put together a 24-page guide applicable to numerous groups of stakeholders.

Bhvita Jani, research manager at the healthcare market analysis firm Signify Research, shares noteworthy happenings from the ECR expo floor.

The research fund aims to track the health of Americans for decades, with the intent of housing the long-term health information of 70% to 90% of the population.

ChatGPT isn’t capable of unilaterally guiding care for patients with cirrhosis or the liver cancer it tends to spawn, hepatocellular carcinoma (HCC). However, the large-language AI tool can competently assist clinicians.  

The interventional cardiologist is now working with vendor Supira Medical to help advance the company's next-generation percutaneous ventricular assist device.

A popular marketer of handheld ultrasound devices has won FDA approval for an AI-enabled B-line quantification tool for use with patients suspected of having compromised lung function.

Radiology AI vendor Bot Image may market its prostate software not only for diagnosing cancer when suspected but also for performing prostate screenings.

Big Tech players have been investing in partnerships with large healthcare providers on AI endeavors for several years now. According to both sides in one such collaboration, the resulting synergy offers “immense potential” to improve patient access, care and outcomes.